Empagliflozin as a Novel Therapy in Refractory Ascites
NCT05430243
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
42
Enrollment
OTHER
Sponsor class
Conditions
Ascites Hepatic
Interventions
DRUG:
Empagliflozin 10 MG
DRUG:
Diuretics
Sponsor
Alexandria University